BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11983831)

  • 1. Dietary copper affects azoxymethane-induced intestinal tumor formation and protein kinase C isozyme protein and mRNA expression in colon of rats.
    Davis CD; Johnson WT
    J Nutr; 2002 May; 132(5):1018-25. PubMed ID: 11983831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary copper and dimethylhydrazine affect protein kinase C isozyme protein and mRNA expression and the formation of aberrant crypts in colon of rats.
    Davis CD; Johnson WT
    Biofactors; 2001; 15(1):11-26. PubMed ID: 11673641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion.
    Reddy BS; Simi B; Patel N; Aliaga C; Rao CV
    Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fat and fiber modulate the effect of carcinogen on colonic protein kinase C lambda expression in rats.
    Jiang YH; Lupton JR; Chapkin RS
    J Nutr; 1997 Oct; 127(10):1938-43. PubMed ID: 9311948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats.
    Verghese M; Rao DR; Chawan CB; Williams LL; Shackelford L
    J Nutr; 2002 Sep; 132(9):2809-13. PubMed ID: 12221250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fish oil blocks carcinogen-induced down-regulation of colonic protein kinase C isozymes.
    Jiang YH; Lupton JR; Chapkin RS
    Carcinogenesis; 1997 Feb; 18(2):351-7. PubMed ID: 9054628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive detection of fecal protein kinase C betaII and zeta messenger RNA: putative biomarkers for colon cancer.
    Davidson LA; Aymond CM; Jiang YH; Turner ND; Lupton JR; Chapkin RS
    Carcinogenesis; 1998 Feb; 19(2):253-7. PubMed ID: 9498273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphodensitometric analysis of protein kinase C beta(II) expression in rat colon: modulation by diet and relation to in situ cell proliferation and apoptosis.
    Davidson LA; Brown RE; Chang WC; Morris JS; Wang N; Carroll RJ; Turner ND; Lupton JR; Chapkin RS
    Carcinogenesis; 2000 Aug; 21(8):1513-9. PubMed ID: 10910952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diets enriched with cereal brans or inulin modulate protein kinase C activity and isozyme expression in rat colonic mucosa.
    Pajari AM; Oikarinen S; Gråsten S; Mutanen M
    Br J Nutr; 2000 Nov; 84(5):635-43. PubMed ID: 11177176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors.
    Dai W; Liu T; Wang Q; Rao CV; Reddy BS
    Int J Oncol; 2002 Jan; 20(1):121-6. PubMed ID: 11743651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis.
    Gökmen-Polar Y; Murray NR; Velasco MA; Gatalica Z; Fields AP
    Cancer Res; 2001 Feb; 61(4):1375-81. PubMed ID: 11245437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta.
    Wali RK; Frawley BP; Hartmann S; Roy HK; Khare S; Scaglione-Sewell BA; Earnest DL; Sitrin MD; Brasitus TA; Bissonnette M
    Cancer Res; 1995 Nov; 55(22):5257-64. PubMed ID: 7585585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV; Hirose Y; Indranie C; Reddy BS
    Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms in the chemoprevention of colon cancer: modulation of protein kinase C, tyrosine protein kinase and diacylglycerol kinase activities by 1,4-phenylenebis-(methylene)selenocyanate and impact of low-fat diet.
    Rao CV; Simi B; Hirose Y; Upadhyaya P; El-Bayoumy K; Reddy BS
    Int J Oncol; 2000 Mar; 16(3):519-27. PubMed ID: 10675484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C isoforms in the chemopreventive effects of a novel vitamin D3 analogue in rat colonic tumorigenesis.
    Wali RK; Bissonnette M; Khare S; Aquino B; Niedziela S; Sitrin M; Brasitus TA
    Gastroenterology; 1996 Jul; 111(1):118-26. PubMed ID: 8698190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red wine and black tea polyphenols modulate the expression of cycloxygenase-2, inducible nitric oxide synthase and glutathione-related enzymes in azoxymethane-induced f344 rat colon tumors.
    Luceri C; Caderni G; Sanna A; Dolara P
    J Nutr; 2002 Jun; 132(6):1376-9. PubMed ID: 12042461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
    Janakiram NB; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.